ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

HROW Harrow Inc

10.32
0.13 (1.28%)
最終更新日: 00:31:46
15分遅延
名称 銘柄コード 市場 種別
Harrow Inc HROW NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.13 1.28% 10.32 00:31:46
始値 安値 高値 終値 前日終値
10.24 10.04 10.44 10.19
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00BWHarrow Will Release First Quarter 2024 Financial Results..
2024/4/0221:16BWMelt Pharmaceuticals Closes $24 Million Series B Preferred..
2024/3/2020:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
2024/3/2006:45BWHarrow Announces Fourth Quarter and Year-End 2023 Financial..
2024/3/1920:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
2024/3/0620:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0521:00BWHarrow Will Release Fourth Quarter and Year-End 2023..
2024/2/2209:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2209:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:15EDGAR2Form 8-K - Current report
2024/2/1606:01BWHarrow Licenses Canadian Rights to Apotex for Five Branded..
2024/2/1006:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0821:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3006:30EDGAR2Form 8-K - Current report
2024/1/3005:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/2921:00BWHarrow Announces New Appointments to its Board of Directors
2024/1/1121:00BWHarrow Announces Availability of VEVYE® (Cyclosporine..
2024/1/1000:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0322:00EDGAR2Form 8-K - Current report
2024/1/0321:15BWMelt Pharmaceuticals Provides Corporate Update
2024/1/0321:00BWHarrow Partners with Leading Healthcare Market Access..
2023/11/2921:00BWHarrow Completes Transfer of the TRIESENCE® New Drug..
2023/11/2021:00BWHarrow to Present at Two Investor Conferences in November
2023/11/1706:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1509:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:34EDGAR2Form 8-K - Current report
2023/11/1406:01BWHarrow Announces Third Quarter 2023 Financial Results
2023/11/0405:52EDGAR2Form 8-K - Current report
2023/10/3021:00BWHarrow Will Release Third Quarter 2023 Financial Results on..
2023/10/2420:00BWHarrow Completes Transfer of NDAs and Launches FLAREX®,..
2023/9/3005:01EDGAR2Form 8-K - Current report
2023/9/2921:00BWHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
2023/9/2621:00BWMelt Pharmaceuticals Announces Exclusive Development and..
2023/9/2107:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1520:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:05EDGAR2Form 8-K - Current report
2023/8/1005:01BWHarrow Announces Second Quarter 2023 Financial Results
2023/7/3120:00BWHarrow Launches VIGAMOX® in the U.S.
2023/7/2622:00BWHarrow to Announce Second Quarter 2023 Financial Results on..
2023/7/2205:02EDGAR2Form 8-K - Current report
2023/7/2108:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2108:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2006:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/1920:00BWHarrow Prices $60 Million Public Offering of Common Stock
2023/7/1911:55BWHarrow erwirbt US-amerikanische und kanadische..
2023/7/1906:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/1906:00BWHarrow Acquires Santen’s Branded Ophthalmic Portfolio
2023/7/1905:59EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock